Enveric Biosciences, Inc. Common Stock ENVB
Key Stats
- Today's Range
- $1.41 – $1.54
- 50-Day Range
- $1.17 – $1.75
- 52-Week Range
- $1.17 – $17.64
- Volume
- 104K shs
- Average Volume
- 110K shs
- Market Cap
- $6.36 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 2.05%
- Days to Cover
- 1.00
About Enveric Biosciences, Inc. Common Stock
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Related Stocks
Compare head-to-head: ENVB vs LLY·ENVB vs JNJ·ENVB vs ABBV·ENVB vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.